Generic Pharmaceuticals And Patentology

tag:blogger.com,1999:blog-16728888428059321842011-08-09T05:18:21.082-07:00Generic Pharmaceuticals And PatentologyThe blog reviews generic pharmaceuticals newsSarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.comBlogger51100tag:blogger.com,1999:blog-1672888842805932184.post-28957536705463867172009-08-26T21:24:00.000-07:002009-08-26T21:30:06.581-07:00Paragraph IV certification reported by USFDA (June-August, 2009)

1. Amlodipine Besylate and Atorvastatin Calcium 5 mg + 80 mg tablets (Caduet) Paragraph IV filed on April 4, 20092. Fluvoxamine Maleate Extended- release Capsules (Luvox CR) Paragraph IV filed for 100 mg strength on May 18, 2009 and for 150 mg strength on April 13, 20093. Minoxidil 5% Topical Aerosol Foam (Men’s Rogaine) Paragraph IV filed on April 6, 20094. Paroxetine Hydrochloride 37.5 mg

Sarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.com0tag:blogger.com,1999:blog-1672888842805932184.post-36894148836938131482009-06-04T22:59:00.000-07:002009-06-04T23:33:07.582-07:00Esomeprazole (Nexium): Generic enter Netherlands

Generic enter NetherlandsReuters article HereGeneric web review HereDetails are Here

Sarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.com0tag:blogger.com,1999:blog-1672888842805932184.post-23259302552768446752009-05-04T22:38:00.000-07:002009-05-04T22:41:07.428-07:00Pregabalin [(S)-3-(Aminomethyl)-5-methylhexanoic acid , Lyrica] 25, 50, 75, 100, 150, 200, 225, 300 mg/capsule: Innovator Pfizer sues 7 generic player

Innovator Pfizer in a bid to protect it’s blockbuster neuropathic pain treatment Pregabalin (Lyrica) against generic challenge has filed patent infringement suit against various generic players on April 29, 2009 in Delaware District Court. The said lawsuit was filed in response to ANDA filed by various generic players on this product for Pregabalin (Lyrica) 25, 50, 75, 100, 150, 200, 225, 300 mg

Sarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.com0tag:blogger.com,1999:blog-1672888842805932184.post-433380808516481032009-04-23T03:01:00.000-07:002009-04-23T03:03:49.327-07:00New Paragraph IV filings reported by USFDA till April 23, 2009

Brimonidine Tartrate and Timolol Maleate 0.2%/0.5% Ophthalmic Solution (Combigan) Para IV filed on Nov 21, 2008Capecitabine 150 mg and 500 mg Tablets (Xeloda). Para IV filed on Nov 10, 2008Diclofenac Sodium and Misoprostol 75 mg/0.2 mg Delayed-release Tablets (Arthrotec) Para IV filed on Nov 28, 2008Guaifenesin and Dextromethorphan 600 mg/30 mg and 1200 mg/60 mg Extended-release Tablets (Mucinex

Sarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.com0tag:blogger.com,1999:blog-1672888842805932184.post-46224902949820545082009-02-04T23:21:00.000-08:002009-02-04T23:25:59.258-08:00Paragraph IV certification reported by USFDA from November 2008 till February 3, 2009

Carbidopa+ Levodopa + Entacapone (Stalevo) Tablets 12.5 mg, 50 mg and 200 mg 50 on August 5, 2008 and 50mg/200mg/200mg on Aug 28, 2008Duloxetine (Cymbalta) Delayed-release Capsules 20 mg, 30 mg and 60 mg on Aug 4, 2008Emtricitabine and Tenofovir Disoproxil (Truvada) Tablets 200 mg/300 mg on September 26, 2008Fluticasone (Cutivate) Lotion 0.05% on July 28, 2008Pramipexole (Mirapex) Tablets 0.75 mg

Sarwalhttp://www.blogger.com/profile/08173434186048743336noreply@blogger.com0